JPRN-UMIN000023676招募中未知
Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneration - Intravitreal anti-VEGF therapy for AMD
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Intravitreal anti-VEGF Therapies for Macular Edema Folowing Retinal Vein OcclusioRetinal vein occlusionJPRN-UMIN000023005Kawasaki Medical School33
已完成
4 期
Early anti-VEGF Therapy Intervention for Retinal Vein OcclusioRetinal vein occlusionJPRN-UMIN000026173Kyoto Prefectural Univerisity of Medicine50
已完成
不适用
Intravitreal bevacizumab(Avastin) for macular edema secondary to uveitis: 1 year results of a prospective pilot studyMacular edema secondary to uveitis.Other specified retinal disordersIRCT138902113846N1Shiraz University of Medical Sciences30
已完成
不适用
Intravitreal Injections by Nurses and Physicians ComparedEye DiseasesNCT02359149St. Olavs Hospital328
已完成
不适用
Intravitreal injection of anti vascular endothelial growth factor agent, Lucentis (ranibizumab), for the treatment of retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000013975agoya University hospital ophtalmoligy30